BIMINI Biotech has been awarded the NWO Take-off Phase 1

BIMINI Biotech has been awarded the NWO Take-off Phase 1 grant (€40.000) in collaboration with the Universitair Medisch Centrum Utrecht (UMCU) to perform an extensive feasibility study for BIMINI’s lead compound. The aim of the grant is to stimulate entrepreneurship and valorisation of breakthrough innovations that originate from Dutch Universities.

This grant will help BIMINI to further accelerate the time-to-market for our innovation.